{"name":"China Resources Biopharmaceutical Co., Ltd","slug":"china-resources-biopharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CRB4101","genericName":"CRB4101","slug":"crb4101","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"CRB4101","genericName":"CRB4101","slug":"crb4101","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQaU9iN3JqdVl0UTdEUmtTMDBDMW1ranlxT09fUTZYdjA0Q19FakNfbUY2Q0ZodmJUT3NUS3h3eFJDZ2FYa0pmQndZNlJ6Nk1aQnJyUnpxdkhfUXpONlJlSUEzV1ZlUEJ0SkltM091RWJ1QmY0ZFNuNlRya3doS1BGX29zWEh2aWxnUFUxQ3pZblp3RjJoeDZXZ1JSMDFWYWxxZVJIY2pBTzRfRllnZmVKZHVZN0RybjVyR01BT1k4amwzRF9Nb0VKSXR3?oc=5","date":"2026-03-26","type":"pipeline","source":"TipRanks","summary":"China Resources Pharma Subsidiary Raises Up to RMB1 Billion in 2026 Bond Issue - TipRanks","headline":"China Resources Pharma Subsidiary Raises Up to RMB1 Billion in 2026 Bond Issue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOYnB4Yi1jd2EzY2xtekY0cDNwX3pNOEhFYWp0TUEzaUcxSEFIMzV2WnptZmFMZ0gyN3lxQ2llb0hHQnZWNWprVHFrd3pxME1PUzJHdVU3VUhMbFN2ckJTRHNiVmJhNGRNblFXWEdMZk16LWZCOUFaN0lPOXFVNDYxdnQwNWtUb1FsYXp4RkU3cjBpYmFLLUs0Q1NGN1lUQVcxRnZrTXdEdWZkVHlYSTAteEI3WU5nTHhad0dTSFdn?oc=5","date":"2026-03-15","type":"pipeline","source":"AD HOC NEWS","summary":"Sinopharm Group Co Ltd Stock (ISIN: HK0000004322) Faces Headwinds Amid China Healthcare Sector Shift - AD HOC NEWS","headline":"Sinopharm Group Co Ltd Stock (ISIN: HK0000004322) Faces Headwinds Amid China Healthcare Sector Shift","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQTkUydDFubEtpdEczQXBzdEFQUWVDcXBJcFZhSVZINEIwOVFabjdfYzZqX29hdVRaYkNoSTRfN0QzWWQ4bGhqU0lDZU0wMml4dUtIYWRZdHZMdlRqSXNsYXVocGNuNVdwaUI2ZlVOR1Q1bExpODY2Y1FDYUVpbE82ZFZWYWRkU3pPVlZ4U1RJZ3pDMkY5eTA3bTZlVzlKa1V4ZFdaMTRNd1lwenNvYmxaVk9SMGtyS09yY2RGZUdtUGRCWHVKVk5mZQ?oc=5","date":"2026-03-14","type":"pipeline","source":"AD HOC NEWS","summary":"Sinopharm Group Co Ltd Stock (ISIN: HK1099000080) Holds Steady Amid China Pharma Sector Shifts - AD HOC NEWS","headline":"Sinopharm Group Co Ltd Stock (ISIN: HK1099000080) Holds Steady Amid China Pharma Sector Shifts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNZ1NhU25Rdnp3eVRoY3NpRHFtNWFoWl9OQjhtMHlCMHZtUGEwUnkyWkpSTFdMeGg4TFNfajh1UVZIUXhxZENZdmk4WnUyNGFrQVROUE4wZXQ0Q1E0RUo2Ql95N1ZGX1ZPRFItY3RGMVQwSU55T1lUV195djNrQlVpZ2RLQWl5REttQ2ZVNGJsd3ZGeWM3WTJxQVZ3YzZ2SUE?oc=5","date":"2026-02-19","type":"pipeline","source":"Statista","summary":"Largest Chinese pharmaceutical companies 2025, by sales value - Statista","headline":"Largest Chinese pharmaceutical companies 2025, by sales value","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-27","type":"pipeline","source":"simplywall.st","summary":"Take Care Before Diving Into The Deep End On China Resources Pharmaceutical Group Limited (HKG:3320) - simplywall.st","headline":"Take Care Before Diving Into The Deep End On China Resources Pharmaceutical Group Limited (HKG:3320)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOMnp0SGhhblN4aU13alE5Q2tmM0NMNGdQMzU0cndVelNTUVRkSDh5aXluLW9JYjlfdW9TM29JRnBtWXVMUDEzczRnS3BWc1RyVzZBdWpfc0otNlQweDVZd1lfaTEtZzh5RGFMV1Y0dE8zZi0yeVhpMU85eVNpRVp4V29RdjFwN2NsanRGcnpnZGlaQkdPUXFYUV9wZUdxVHZWVVoybnY3cDNIbTNySGpUU1FNcnVxOERwdkpBejdVckY0akhybkVwdzU1TXViUlA5Vmc?oc=5","date":"2025-10-15","type":"pipeline","source":"Hong Kong Science & Technology Parks Corporation ('HKSTP'","summary":"AusMed Global and China Resources Guangdong Pharmaceutical Sign Strategic Agreement to Accelerate Medical Innovation in the Greater Bay Area - Hong Kong Science & Technology Parks Corporation ('HKSTP'","headline":"AusMed Global and China Resources Guangdong Pharmaceutical Sign Strategic Agreement to Accelerate Medical Innovation in ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNYktIV2VIa2V0em5UMzdmUFRYQUpGaXVXYkRLSWJMXzE2THhnY3VuTlppemRRUENnT3g4MXVPNEtDZ2lVRjFiVDBOeTZFajJGVUFSUlJwRTNZWkpFSmdiQUR1MlRQQ2pxZU1ZcjFESDU5TjNjNjJLNmxEa1FpRFhUM1ZBNzdvQQ?oc=5","date":"2025-09-15","type":"deal","source":"JD Supra","summary":"Merger Control in China’s Healthcare Industry: Insights into Antitrust Review and Market Trends - JD Supra","headline":"Merger Control in China’s Healthcare Industry: Insights into Antitrust Review and Market Trends","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9JUG5ZTlkxVFlFeTlIQkxwVWliZmZmRHZoajIyVGp0LS1QWTFJX2tPNjRVUFE4ZGxSaWhwNmJVUFN1UHFZQVYzaWJkaWN6dDdTSWJVakdWZmoycUNNbU9TYXoyeE5VOUZHY3hkV2UwZG1GM2owYnpMcndR?oc=5","date":"2025-09-03","type":"pipeline","source":"Growth Dragons","summary":"China Resources: From Snow Beer to Microchips - How One Company Touches Every Part of Life in China - Growth Dragons","headline":"China Resources: From Snow Beer to Microchips - How One Company Touches Every Part of Life in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPQm5Bb2ZDM2VWb0hRY3VGOWFSekdBV25HVUhFVk83YzBsZlQ2VHl4T1NKS1RpcjR4T2dDUl9rOXBwaTZ6dkZJSWkzUmZTZjZNVEdwRDZOWlBLU1BQdmJzSEVkb2V4emFVTGwyUFIxOEV2emwyQUN5SlBSQ01HRVBReTRwdzR1dm5oZUZQQTNFQ3dBcGJfX1ZpV2hZYlpkdFhWZG5MSm5jV1RhcS1KVUNXRExXYXQ1SkdWX2gzbi0wMDZEZTA?oc=5","date":"2025-07-13","type":"pipeline","source":"Bloomberg.com","summary":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline - Bloomberg.com","headline":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE16NkVVY0xRZWNvdTJPVnRaVVFzTTRTWmg2U3lnNEppNzRhYnNSOG9SU1hkMXBXdllKR1JTYjhsalU4RkEwZFctVzltdkZmTnRxMWFn?oc=5","date":"2024-12-25","type":"pipeline","source":"君合","summary":"JunHe Advises CR Pharmaceutical Commercial on its Strategic Cooperation with Pfizer - 君合","headline":"JunHe Advises CR Pharmaceutical Commercial on its Strategic Cooperation with Pfizer - 君合","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQRVZYb2o2dU1CWGp0bGg3Q2drcnE0dEVsTjludnpsVHBScW9tZGZ0V0g3d04zY2xXUF81UVQ3TjhHY2lxMkpWRmppbWQ2NE4yblcwODJyd19MNW9GRUlrdEJZVzBsbE96bk1Kb1R1Qm40TTVnV3J2VWk5MVNyN0J0b0laRks1MmZEUDdsZDRUT0RxcXJ5aHB6VkgtUVk3WVhrWFZTOG1fenBvUWRMaUROdklNdw?oc=5","date":"2024-09-11","type":"regulatory","source":"Morgan Lewis","summary":"China Boosts Regulatory Framework for Local Pharmaceutical Manufacturing - Morgan Lewis","headline":"China Boosts Regulatory Framework for Local Pharmaceutical Manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOQlpsaFE1aW5td2FCSmVJZHBYSGhCQTFwNmY0eUVjZUJwcjR1VVNOZ04ySWUzRkhfTjh1VkNseFdMS2FGVTdYS2c3YXY5SlRQRkt5ZENMa2dKckl0ZWtFMmw4d1JaRTRuUWc4TnVuNWMzQnRQOFJoT1RVZkxYNU1SWFhtVDFnUWIwUDhUdDhCc0RWODJYZGo3SWtlU29KZXhyakFHUl9FcUMzQUh0UXVnM0paV1dkenpNakZua3JOZmRGOWpTS3RtYm40dU0wM09xN1Nka2lmdG9renpZ?oc=5","date":"2022-05-12","type":"pipeline","source":"Reuters","summary":"China Resources in talks to take Sihuan Pharma private at $3 bln valuation -sources - Reuters","headline":"China Resources in talks to take Sihuan Pharma private at $3 bln valuation -sources","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}